Sol-Gel Technologies (SLGL) Cash & Equivalents (2016 - 2026)

Sol-Gel Technologies' (SLGL) quarterly Cash & Equivalents came in at $10.1 million in Q1 2026, down 39.99% year-on-year from $16.9 million in Q1 2025, and down 8.13% on a QoQ basis from $11.0 million in Q4 2025.

Sol-Gel Technologies (SLGL) Cash & Equivalents (2016 - 2026) Analysis & Trends

Sol-Gel Technologies (SLGL) has 11 years of Cash & Equivalents data on file, last reported at $10.1 million in Q1 2026.

  • On a quarterly basis, Cash & Equivalents fell 39.99% year-over-year to $10.1 million in Q1 2026; TTM through Mar 2026 was $10.1 million, a 39.99% decrease from a year earlier, with the FY2025 full-year figure at $11.0 million, down 46.61% from the prior year.
  • Cash & Equivalents for Q1 2026 stood at $10.1 million, down from $11.0 million in the prior quarter.
  • Over the last five years, Cash & Equivalents for SLGL reached as high as $21.3 million in Q1 2022 and fell as low as $6.7 million in Q3 2025.
  • Historically, Cash & Equivalents has averaged $13.6 million across 5 years, with a median of $12.7 million in 2024.
  • Across the five-year window, Cash & Equivalents sank 80.39% in 2022 and jumped 159.4% in 2024, its largest moves.
  • Year by year, Cash & Equivalents stood at $12.4 million in 2022, then sank by 39.64% to $7.5 million in 2023, then surged by 159.4% to $19.5 million in 2024, then sank by 43.39% to $11.0 million in 2025, then declined by 8.13% to $10.1 million in 2026.
  • Per Business Quant data, the three most recent Cash & Equivalents figures were $10.1 million in Q1 2026, $11.0 million in Q4 2025, and $6.7 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 82.45 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - 61.40 Mn
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 4.79 Bn
4 NuCana 279.75 Bn 279.75 Bn - 32.26 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 5.49 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 2.96 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 3.58 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn - 440.94 Mn
10 Sol-Gel Technologies 227.58 Mn 217.44 Mn - 10.14 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 10.14 Mn
Dec 31, 2025 11.03 Mn
Sep 30, 2025 6.71 Mn
Jun 30, 2025 20.67 Mn
Mar 31, 2025 16.89 Mn
Dec 31, 2024 19.49 Mn
Sep 30, 2024 13.42 Mn
Jun 30, 2024 12.71 Mn
Mar 31, 2024 11.21 Mn
Dec 31, 2023 7.51 Mn
Sep 30, 2023 14.14 Mn
Jun 30, 2023 16.79 Mn
Mar 31, 2023 6.81 Mn
Dec 31, 2022 12.45 Mn
Sep 30, 2022 8.50 Mn
Jun 30, 2022 21.24 Mn
Mar 31, 2022 21.25 Mn
Dec 31, 2021 20.09 Mn
Sep 30, 2021 43.35 Mn
Jun 30, 2021 12.30 Mn